Comerica Securities,Inc. Regeneron Pharmaceuticals, Inc. Transaction History

Comerica Securities,Inc.

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 Apr 27, 2023	SELL	$680.49 - $826.97 $1,360 - $1,653	-2 Reduced 0.7%	283 $232,000
Q4 2022 Feb 10, 2023	BUY	$705.89 - $766.39 $201,178 - $218,421	285 New	285 $205,000
Q1 2022 Apr 28, 2022	SELL	$595.12 - $698.43 $303,511 - $356,199	-510 Closed	0 $0
Q4 2021 Feb 10, 2022	SELL	$543.48 - $670.97 $25,000 - $30,864	-46 Reduced 8.27%	510 $322,000
Q3 2021 Nov 10, 2021	SELL	$574.03 - $680.96 $93,566 - $110,996	-163 Reduced 22.67%	556 $336,000
Q2 2021 Aug 11, 2021	SELL	$472.8 - $558.54 $49,171 - $58,088	-104 Reduced 12.64%	719 $402,000
Q1 2021 May 12, 2021	BUY	$446.73 - $548.2 $167,077 - $205,026	374 Added 83.3%	823 $389,000
Q4 2020 Feb 09, 2021	BUY	$478.3 - $607.98 $214,756 - $272,983	449 New	449 $217,000
Q3 2020 Nov 04, 2020	SELL	$544.75 - $658.21 $695,101 - $839,875	-1,276 Closed	0 $0
Q2 2020 Jul 17, 2020	BUY	$493.32 - $643.92 $142,076 - $185,448	288 Added 29.15%	1,276 $796,000
Q3 2019 Oct 15, 2019	BUY	$273.46 - $318.39 $270,178 - $314,569	988 New	988 $369,000

1,534

83.6M

1.22M

1.51M

Ticker REGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,190,000
Market Cap $75.2B
Description
Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...

Get notified when there are updates to the investment portfolio of Comerica Securities,Inc., based on Form 13F filings with the SEC.

Stay updated on Comerica Securities,Inc. with notifications on news.